Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heart failure in the community

N Sharpe1

  • 1Department of Medicine, University of Auckland, New Zealand.

Progress in Cardiovascular Diseases
|August 26, 1998
PubMed
Summary
This summary is machine-generated.

Heart failure is a growing concern, especially for older adults. Current clinical trial data is difficult to apply to community patients due to differences in age and health conditions, necessitating better guideline implementation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epoprostenol increased mortality in patients with severe CHF.

Evidence-based cardiovascular medicine·2005
Same author

Uptake of self-management strategies in a heart failure management programme.

European journal of heart failure·2003
Same author

Factors influencing the length of hospital stay of patients with heart failure.

European journal of heart failure·2003
Same author

Matching the standards of clinical trial evidence with application in practice.

International journal of clinical practice·2003
Same author

Optimization of ACE inhibitor therapy in heart failure.

European heart journal·2002
Same author

The effects of intensive glycaemic control on body composition in patients with type 2 diabetes.

Diabetes, obesity & metabolism·2002
Same journal

Beyond therapeutic maximalism: Prioritization and personalization in preventive therapies.

Progress in cardiovascular diseases·2026
Same journal

Multimodality imaging of vulnerable plaque: Are we there yet? A multifaceted perspective.

Progress in cardiovascular diseases·2026
Same journal

Beyond LDL-C: Triangulating residual risk via lipoprotein(a), remnant cholesterol, and vascular inflammation.

Progress in cardiovascular diseases·2026
Same journal

COVID-19 and coronary atherosclerosis: Unmasking and accelerating?

Progress in cardiovascular diseases·2026
Same journal

Mavacamten and left ventricular dysfunction in hypertrophic cardiomyopathy with left bundle branch block.

Progress in cardiovascular diseases·2026
Same journal

Lessons from ATTR-CM clinical trials: Progress, persistent disparities, and emerging treatment dilemmas.

Progress in cardiovascular diseases·2026
See all related articles

Area of Science:

  • Geriatrics
  • Cardiology
  • Public Health

Background:

  • Heart failure (HF) is a prevalent and increasing health issue, disproportionately affecting the elderly population.
  • Existing clinical trial data for HF management faces challenges in direct translation to community-based patient care.
  • Elderly patients often present with higher comorbidity rates and distinct HF characteristics compared to younger cohorts.

Purpose of the Study:

  • To highlight the challenges in applying clinical trial data to the broader elderly heart failure patient population.
  • To emphasize the need for improved strategies in implementing best practice guidelines for heart failure.
  • To underscore the importance of an integrated healthcare approach for optimizing long-term outcomes in elderly patients with heart failure.

Main Methods:

Related Experiment Videos

  • Review of existing literature on heart failure clinical trials and community-based patient data.
  • Analysis of demographic and comorbidity differences between trial participants and the general elderly population.
  • Examination of factors influencing the implementation of practice guidelines in primary and secondary care settings.

Main Results:

  • Clinical trial participants are often highly selected, differing significantly from typical community-dwelling elderly patients with heart failure.
  • Older patients with heart failure commonly exhibit greater comorbidity, impacting treatment efficacy and generalizability of trial findings.
  • Current implementation of heart failure guidelines may not fully address the complexities of elderly patients in real-world settings.

Conclusions:

  • Effective heart failure management in the elderly requires acknowledging the limitations of current clinical trial data.
  • Bridging the gap between trial evidence and community practice necessitates tailored guideline implementation strategies.
  • An integrated approach involving primary and secondary care physicians, alongside enhanced patient participation, is crucial for optimizing long-term outcomes in elderly heart failure patients.